Mild Cognitive Impairment
Mild Cognitive Impairment

Author: Ronald C. Petersen

Publisher: Oxford University Press

Published: 2003-01-09

Total Pages: 286

ISBN-13: 0198028741

DOWNLOAD EBOOK

What are the boundary zones between normal aging and Alzheimer's disease (AD)? Are many elderly people whom we regard as normal actually in the early stages of AD? Alzheimer's disease does not develop overnight; the early phases may last for years or even decades. Recently, clinical investigators have identified a transitional condition between normal aging and and very early Alzheimer's disease that they have called mild cognitive impairment, or MCI. This term typically refers to memory impairment beyond what one would expect in individuals of a given age whose other abilities to function in daily life are well preserved. Persons who meet the criteria for mild cognitive impairment have an increased risk of progressing to Alzheimer's disease in the near future. Though many questions about this condition and its underlying neuropathology remain open, full clinical trials are currently underway worldwide aimed at preventing the progression from MCI to Alzheimer's disease. This book addresses the spectrum of issues involved in mild cognitive impairment, and includes chapters on clinical studies, neuropsychology, neuroimaging, neuropathology, biological markers, diagnostic approaches, and treatment. It is intended for clinicians, researchers, and students interested in aging and cognition, among them neurologists, psychiatrists, geriatricians, clinical psychologists, and neuropsychologists.

Mild Cognitive Impairment and Early Alzheimer's Disease
Mild Cognitive Impairment and Early Alzheimer's Disease

Author: Jeffrey M. Burns

Publisher: John Wiley & Sons

Published: 2008-05-27

Total Pages: 168

ISBN-13:

DOWNLOAD EBOOK

Written by leading authorities in the field, this book describes the cognitive changes associated with age, the earliest detectable stages of Alzheimer’s, and the relationship of these conditions to MCI. The authors review the latest advances in our understanding of MCI, its prevalence, evaluation, management, and outcomes and in so doing provide practising physicians with a useful resource that assists them in identifying those MCI patients who will progress to recognised Alzheimer’s Disease. Beautifully presented in full colour, Early Diagnosis and Treatment of Mild Cognitive Impairment includes case studies and discusses future therapeutic and diagnostic strategies. It is an invaluable resource for postgraduates and professionals, for specialist physicians in neurology and psychiatric medicine, geriatric medicine and general practice.

Mild Cognitive Impairment
Mild Cognitive Impairment

Author: Holly A. Tuokko

Publisher: Psychology Press

Published: 2019-12-23

Total Pages: 343

ISBN-13: 1000037851

DOWNLOAD EBOOK

The Classic Edition of this foundational text includes a new preface from Holly A. Tuokko, examining how the field of Mild Cognitive Impairment (MCI) has developed since first publication. Bringing together research from multiple studies and perspectives from various countries, the volume identifies MCI as an important clinical transition between normal aging and the early stages of Alzheimer's disease (AD). The up-to-date preface highlights the expansion in research, examining the benefits of various pharmacological, cognitive and behavioral approaches to intervention. Influenced by recent findings in neuroplasticity across the lifespan, the book recognizes the importance of intervention at the earliest stages of the decline trajectory. It revisits the contested diagnostic approaches for MCI as well as the varying prevalence of MCI internationally, yet points to the need for further longitudinal studies to fully understand the condition. Mild Cognitive Impairment continues to provide a comprehensive resource for clinicians, researchers and students involved in the study, diagnosis, treatment and rehabilitation of people with MCI.

Computerized Cognitive Testing
Computerized Cognitive Testing

Author: Christian Elliott

Publisher:

Published: 2011-05-30

Total Pages: 66

ISBN-13: 9780615536613

DOWNLOAD EBOOK

A review of cognitive health screening tools for the doctor's office, health clinic, and other primary care settings.We are at the front edge of a rising wave of Alzheimer's and other dementia impairment as the population ages, and this wave of millions will severely strain national health care systems. MyBrainTest has identified and researched several computerized cognitive health screening tools that can be administered in the physician's office to screen for cognitive impairment. Products reviewed include Brain Resource (WebNeuro), Cambridge Cognition (CANTAB), CNS Vital Signs, CogState, HeadMinder CST, Medical Care Corp. (MCI-Screen), MedInteract (Computer Self Test-ALZselftest), MemTrax, NeuroTrax (MindStreams), Psychology Software Tools (CAMCI), and Screen Inc (CANS-MCI).

Living with Mild Cognitive Impairment
Living with Mild Cognitive Impairment

Author: Nicole D. Anderson

Publisher: Oxford University Press

Published: 2012-08-23

Total Pages: 384

ISBN-13: 0199764824

DOWNLOAD EBOOK

This book is for individuals with mild cognitive impairment (MCI), their loved ones, and health care professionals who care for these patients. The text is loaded with up-to-date, scientifically substantiated knowledge about what MCI is, how it affects people, and how to take a proactive approach to health and wellbeing for living with MCI.

Neurology in Clinical Practice
Neurology in Clinical Practice

Author: Walter George Bradley

Publisher:

Published: 2004

Total Pages: 1672

ISBN-13: 9780750674690

DOWNLOAD EBOOK

New edition, completely rewritten, with new chapters on endovascular surgery and mitochrondrial and ion channel disorders.

White Matter Dementia
White Matter Dementia

Author: Christopher M. Filley

Publisher: Cambridge University Press

Published: 2016-04-28

Total Pages: 231

ISBN-13: 1107035414

DOWNLOAD EBOOK

Presenting the novel concept of white matter dementia, this unique book offers hope for a better understanding and treatment of dementia.

Finding the Path in Alzheimer’s Disease
Finding the Path in Alzheimer’s Disease

Author: Sharon Cohen, MD, FRCPC

Publisher: Integritas Communications

Published: 2020-11-19

Total Pages: 39

ISBN-13:

DOWNLOAD EBOOK

AD is a common neurodegenerative condition that results in a range of profoundly disabling cognitive, affective, and behavioral symptoms. It affects approximately 5.8 million Americans. Barring significant clinical efforts and medical breakthroughs that prevent or slow disease development, current estimates suggest that by 2050, AD will afflict 14 million patients in the United States. PCPs are on the front lines of early diagnosis of AD, yet many say they feel unprepared and their community lacks adequate specialists in this area. Signs and symptoms of mild cognitive impairment (MCI) and even early AD are often conflated with normal aging, leading to late or missed diagnosis. This is compounded by the lack of a sense of urgency for early, accurate diagnosis because there are no disease-modifying therapies to treat MCI or AD. This eHealth Source activity reviews the pathophysiology of AD, early signs and symptoms, diagnosis first steps, referral patterns, more-complex diagnostic procedures, and existing nonpharmacologic and pharmacologic management strategies. Drs Cohen and Turner provide expert insight into how PCPs can tailor their practice to better care for these patients.

Vascular Disease, Alzheimer's Disease, and Mild Cognitive Impairment
Vascular Disease, Alzheimer's Disease, and Mild Cognitive Impairment

Author: David J. Libon

Publisher: Oxford University Press

Published: 2020-01-23

Total Pages: 368

ISBN-13: 0190634243

DOWNLOAD EBOOK

Alzheimer's disease (AD) and vascular dementia (VaD) are commonly viewed as the first and second most common types of dementia, respectively. The traditional paradigm has been to view and treat each illness as a separate entity with a separate pathophysiology. However, clinical and pathological studies suggest that the boundary separating AD and VaD, as well as their mild cognitive impairment (MCI) analogs, is not well defined. Thus, there is increased interest in viewing these diseases along a spectrum because of the significant overlap in the characterization and diagnosis of AD, VaD, and MCI. The focus of this edited volume is to examine how AD and VaD, as well as their MCI analogs, are best viewed as a heterogeneous, intersecting, if not a continuous disease state rather than separate, distinct entities. This book examines this approach by providing empirically based evidence, reviews of the literature, and chapters by key leaders in the field and will be of interest to clinical neuropsychologists and anyone studying or treating dementia in its many forms.